While much of the literature has focused on identifying predictors of a positive response to CGRP-targeted treatments [16], our study highlights key factors associated with non-response to ERE, including hypertension, smoking, insomnia treated with medication, and RAMP1 rs6431564 polymorphism. The gene discussed is RAMP1; the disease is Hypertension.